Immunoaffinity purification of a-momorcharin from bitter melon seeds (Momordica charantia)

10Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

α-Momorcharin (α-MMC), a type I ribosome-inactivating protein (RIP), has shown therapeutic potential such as anti-tumor and anti-viral agent. Traditional process of α-MMC purification from bitter melon seeds was time consuming and low efficient. To take this challenge, we made an affinity matrix by coupling the monoclonal antibody (McAb) with Sepharose 4B. Using this attractive strategy, 196 mg of α-MMC was obtained from 100 g of bitter melon seeds as the starting material. The yield of the protein was 2.7%. The homogeneity and properties of the protein were assessed by SDS-PAGE, acidic PAGE, RPHPLC and N-terminal sequence as well as Western blot. Purified α-MMC showed remarkable inhibition to the melanoma cell line JAR and EMT-62058. In addition, it also displayed obvious inhibition on hepatitis B virus (HBV). This work provided a simple, rapid and efficient approach for α-MMC purification from Momordica charantia. © 2011 WILEY-VCH Verlag GmbH &Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Yao, X., Li, J., Deng, N., Wang, S., Meng, Y., & Shen, F. (2011). Immunoaffinity purification of a-momorcharin from bitter melon seeds (Momordica charantia). Journal of Separation Science, 34(21), 3092–3098. https://doi.org/10.1002/jssc.201100235

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free